Sort
10,766 grants matching “checkpoint inhibitor”
Immunoediting in Cutaneous Squamous Cell Carcinoma
$42,097Elizabeth Borden · University Of Arizona · F30 · FY2023 · CA
The Effects of Obesity on the Efficacy of Immunotherapy
$42,080Stephanie Dudzinski · Vanderbilt University · F30 · FY2020 · CA
Investigation of Immunotherapy-induced Alterations to Cellular Communication Networks in Pancreatic Ductal Adenocarcinoma
$42,074Jacob Thomas Mitchell · Johns Hopkins University · F31 · FY2024 · CA
Elucidating the distinct roles of T cell-polarized microglia in glioblastoma suppression and progression
$42,030Lizmarie Garcia-Rivera · Salk Institute For Biological Studies · F31 · FY2025 · CA
The roles of AP-1 pathway activation in NK cell development and exhaustion programming in AML
$42,007Erin G. Jeremy · Ohio State University · F30 · FY2023 · CA
B7x in Cancer: Mechanisms and Therapies
$41,995Peter John · Albert Einstein College Of Medicine · F30 · FY2018 · CA
FOXA1 loss-of-function induces inflammatory cytokine signaling and immune suppression in prostate cancer
$41,965Lourdes Brea · Northwestern University At Chicago · F31 · FY2022 · CA
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma
$41,749Connor Patrick Francis · University Of Florida · F30 · FY2022 · CA
Targeting intracellular trafficking for cancer therapy
$41,574Brendan Tyler Finicle · University Of California-Irvine · F99 · FY2022 · CA
Combining Radiation, Allogeneic Natural Killer Immunotherapy, and PD-L1 blockade in Dogs with Naturally-Occurring Melanoma
$41,568Aryana Razmara · University Of California At Davis · F30 · FY2024 · CA
Macrophage Ron signaling regulates the antitumor immune response in prostate cancer
$41,545Camille Sullivan · University Of Cincinnati · F31 · FY2018 · CA
Brachytherapy to achieve in situ cancer vaccination
$41,540Justin Charles Jagodinsky · University Of Wisconsin-Madison · F30 · FY2022 · CA
Elucidating the distinct roles of T cell-polarized microglia in glioblastoma suppression and progression
$41,466Lizmarie Garcia-Rivera · Salk Institute For Biological Studies · F31 · FY2024 · CA
Dissecting the Role of Radiation in Regulation of MHC-I and Neoantigen Presentation
$41,419Chang Su · Duke University · F30 · FY2024 · CA
Immunology Research Program
$41,357Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · P30 · FY2024 · CA
Glut1+ cancer associated fibroblasts enforce a metabolic barrier to tumor T cell infiltration
$41,294Marina T Broz · Cedars-Sinai Medical Center · F31 · FY2023 · CA
Role of Neurogenesis in Depression and Antidepressant Efficacy
$41,176Jennifer Onksen · University Of Pennsylvania · F31 · FY2009 · MH
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma
$41,033Connor Patrick Francis · University Of Florida · F30 · FY2021 · CA
Pglyrp3 cooperates with Snail1 to mediate anti-tumor immune response in breast cancer
$40,989Mathew Sebastian · University Of Florida · F30 · FY2019 · CA
Target validation of CD206 activators
$40,790Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Program 12: Developmental Therapeutics
$40,758Geoffrey I Shapiro · Dana-Farber Cancer Inst · P30 · FY2024 · CA
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response
$40,735Yi Huang · University Of Iowa · R01 · FY2024 · CA
Development of Novel Therapies for HIV Infection
$40,729Robert Yarchoan · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
In Vivo Imaging of Mitochondria Structure and Function in Therapy Resistant Lung Tumors
$40,651David B Shackelford · University Of California Los Angeles · R01 · FY2023 · CA
Characterizing and Overcoming MHC-I-Mediated Immune Evasion in Triple-Negative Breast Cancer
$40,628Dina O'Connell · Univ Of North Carolina Chapel Hill · F31 · FY2025 · CA